SUPN - SUPERNUS PHARMACEUTICALS INC
This page shows which of the focused investors we track hold SUPN and how their positions changed, so you can see how much conviction the group has in the stock.
In Q3 2022 it was held by 3 managers with an aggregate reported value of $24.9M, which is 0.00% of the combined portfolio.
As of Q3 2022, 3 tracked institutional managers held SUPN (SUPERNUS PHARMACEUTICALS INC) with an aggregate reported value of $24.9M — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades SUPN — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q3 2022
- Ticker
- SUPN
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Lee Ainslie - Maverick Capital | 0.01% | New | 8,886 | $301K |
| 2 | Third Avenue Management - Third Avenue Management | 0.02% | - | 2,460 | $84K |
Other instruments
Bonds, warrants, or other non-share-class principal positions in SUPN.
| 1 | Howard Marks - Oaktree Capital Management | Add +2.9% | 25,143,000 | $24.51M |
Loading holder history for SUPN…